Adipositas Care & Health Therapy

NCT04768127 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 586

Last updated 2025-04-08

No results posted yet for this study

Summary

ACHT - Adipositas Care and Health Therapy - is a structured, digitally-supported, cross-sectoral and close to home program developed for the postoperative care of patients following obesity surgery. The aim is to ensure the long-term success of therapy following bariatric surgery. ACHT was selected by the Federal Joint Commission for support under the Innovation Fund. The project started in July 2019 and will end in December 2022.

Conditions

  • Patients After Metabolic-bariatric Surgery
  • Obesity, Morbid

Interventions

OTHER

early aftercare

This group begins the aftercare program immediately after their bariatric surgery.

OTHER

mid-term to late aftercare

This group begins the aftercare program 18 months post surgery.

Sponsors & Collaborators

  • Deutsche Stiftung für chronisch Kranke

    collaborator UNKNOWN
  • Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie e.V. (DGAV)

    collaborator UNKNOWN
  • AOK Bayern

    collaborator INDUSTRY
  • Kassenärztliche Vereinigung Bayern

    collaborator UNKNOWN
  • symeda GmbH

    collaborator UNKNOWN
  • AMC Wolfartklinik Gräfelfing

    collaborator UNKNOWN
  • Schön Klinik Nürnberg Fürth

    collaborator UNKNOWN
  • Dr. Lubos Kliniken Bogenhausen

    collaborator UNKNOWN
  • Klinikum Memmingen

    collaborator UNKNOWN
  • Klinikum Passau

    collaborator UNKNOWN
  • Klinikum Nürnberg

    collaborator OTHER
  • Helmholtz Zentrum München

    collaborator INDUSTRY
  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Bettina Zippel-Schultz, PhD · Deutsche Stiftung für chronisch Kranke

  • Martin Fassnacht, MD · Wuerzburg University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2022-11-30
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04768127 on ClinicalTrials.gov